Basic Study
Copyright ©The Author(s) 2022.
World J Gastrointest Oncol. Feb 15, 2022; 14(2): 450-477
Published online Feb 15, 2022. doi: 10.4251/wjgo.v14.i2.450
Figure 3
Figure 3 The docking model of boswellic acid and stigmasterol with key targets. A: Boswellic acid with AKT1; B: Boswellic acid with VEGFA; C: Boswellic acid with EGFR; D: Stigmasterol with AKT1; E: Stigmasterol with VEGFA; F: Stigmasterol with EGFR.